Items are needed to complete research milestones for DR. Myers react project. Seizure modules
Ended Awarded Last action
- Contract number
- HT009025FG0110012
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,984
Award facts
- Contract value 100% obligated
- $24,984.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $24,984.47 firm fixed-price blanket purchase agreement (BPA) call order to Harvard Bioscience Inc., operating as Data Sciences International, on January 22, 2025. This task order is issued under Harvard Bioscience's existing single-award BPA with the Defense Health Agency, valued at $4.8 million and awarded in May 2022 with completion through May 3, 2027. The procurement provides items required to complete research milestones for Dr. Myers' REACT project, specifically seizure modules that support the company's specialized biomedical research equipment and services. Performance will occur at Harvard Bioscience's facility in Mounds View, Minnesota, with an ultimate completion date of September 30, 2025.
Harvard Bioscience is a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializing in physiological monitoring technologies, wireless implantable telemetry transmitters, respiratory monitoring systems, and data acquisition software for preclinical and medical research. The company serves as a critical supplier to multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, Environmental Protection Agency, and the U.S. Army Medical Command. Under the existing Defense Health Agency BPA, task orders have cumulatively generated over $1.5 million in procurement value, demonstrating the strategic importance of Harvard Bioscience's specialized biomedical solutions to defense and military health sector research initiatives.
Quick answers
Who was awarded contract HT009025FG0110012?
HT009025FG0110012 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on January 22, 2025.
How much is contract HT009025FG0110012 worth?
The government has obligated $24,984 on HT009025FG0110012.
Is contract HT009025FG0110012 an order under another contract?
Yes. HT009025FG0110012 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT009025FG0110012 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award